Cargando…

Immunosuppression for COVID-19: repurposing medicines in a pandemic

Detalles Bibliográficos
Autores principales:	Shivakumar, Senthuran, Smibert, Olivia C, Trubiano, Jason A, Frauman, Albert G, Liew, David FL
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	NPS MedicineWise 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450778/ https://www.ncbi.nlm.nih.gov/pubmed/32921881 http://dx.doi.org/10.18773/austprescr.2020.037

Ejemplares similares

The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19
por: Robinson, Philip C., et al.
Publicado: (2020)

The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19)
por: Drewett, George P., et al.
Publicado: (2021)

Assessing Low-Risk Penicillin Allergies in Critical COVID-19, A Novel Perspective on an Emerging Antibiotic Allergy Opportunity
por: Rose, Morgan, et al.
Publicado: (2023)

1578. Back to Bactrim–Utilizing Preferred Prophylaxis Strategies in Immunocompromised Hosts Via a Trimethoprim-Sulfamethoxazole Rechallenge Program
por: Smibert, Olivia, et al.
Publicado: (2018)

The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
por: Copaescu, Ana, et al.
Publicado: (2020)

Drug repurposing strategies for COVID-19
por: Senanayake, Suranga L
Publicado: (2020)

Repurposing immunosuppressants for antileukemia therapy
por: Sezaki, Maiko, et al.
Publicado: (2022)

The paradox of immunosuppressants and COVID-19
por: Cheng, Guang-Shing, et al.
Publicado: (2022)

1787. The Safety and Efficacy of an Oral Penicillin Rechallenge Program in Cancer Patients: A Pilot Multicenter Study
por: Smibert, Olivia, et al.
Publicado: (2018)

The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study
por: Copaescu, Ana, et al.
Publicado: (2021)

Repurposing Cardio-Metabolic Drugs to Fight Covid19
por: Battistoni, Allegra, et al.
Publicado: (2021)

2743. Pre-Transplant Human T-Lymphotropic Virus Screening In Allogeneic Hematopoietic Stem Cell Transplant Recipients At A Large Metropolitan Tertiary Referral Centre In Melbourne, Australia
por: Paykin, Gabriel, et al.
Publicado: (2023)

Dental medicine and COVID-19 pandemic
por: Brkić, Hrvoje
Publicado: (2020)

Repurposing an ‘Old’ Drug for the Treatment of COVID-19-Related Cytokine Storm
por: Pontali, Emanuele, et al.
Publicado: (2023)

Anticoagulants and Immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS
por: Turi, S, et al.
Publicado: (2020)

Repurposing Antimalarials to Tackle the COVID-19 Pandemic
por: Krishna, Sanjeev, et al.
Publicado: (2021)

To immunosuppress: whom, when and how? That is the question with COVID-19
por: Winthrop, Kevin L, et al.
Publicado: (2020)

Cardiovascular medicine in the era of COVID-19 pandemics
por: Ren, Jun
Publicado: (2021)

Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19
por: Morselli Gysi, Deisy, et al.
Publicado: (2020)

COVID-19 pandemic: guidance for nuclear medicine departments
por: Paez, D., et al.
Publicado: (2020)

Computational drug repurposing in the age of COVID-19: mixing antiviral cocktails in silico
por: Diao, James A., et al.
Publicado: (2022)

Network medicine framework for identifying drug-repurposing opportunities for COVID-19
por: Morselli Gysi, Deisy, et al.
Publicado: (2021)

Impact of Nutrition or FDA-Approved Medicine Repurposing on Metabolic Syndrome and Diabetic Complications
por: Cai, Lu
Publicado: (2023)

Will Evidence-based Medicine Survive the COVID-19 Pandemic?
por: Serpa Neto, Ary, et al.
Publicado: (2020)

The COVID-19 pandemic and Occupational Medicine: impact and opportunities
por: De Matteis, Sara, et al.
Publicado: (2021)

The aftermath of the COVID-19 pandemic on oral medicine practice
por: Patton, Lauren L.
Publicado: (2022)

The role of laboratory medicine specialists in the COVID-19 pandemic
por: Buño Soto, Antonio
Publicado: (2020)

Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection—Implications for Therapeutic Monitoring and Therapeutic Targets
por: Drewett, George P., et al.
Publicado: (2021)

Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders
por: Villoutreix, Bruno O., et al.
Publicado: (2020)

Challenges for Drug Repurposing in the COVID-19 Pandemic Era
por: Sultana, Janet, et al.
Publicado: (2020)

Repurposing drugs during the COVID-19 pandemic and beyond
por: Ravi, Srividya, et al.
Publicado: (2021)

Repurposing Tecfidera for cancer
por: Booth, Laurence, et al.
Publicado: (2016)

Combating COVID-19: The role of drug repurposing and medicinal plants
por: Khan, Shah A., et al.
Publicado: (2021)

Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19
por: Redhead, Martin A., et al.
Publicado: (2021)

Antidepressant drug treatment protecting from COVID-19: one more piece in the repurposing puzzle
por: Stingl, Julia C.
Publicado: (2021)

Pandemic medicine: the management of advanced melanoma during COVID-19
por: Patrinely, James R, et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on nuclear medicine departments in Europe
por: Moreira, Ana Paula, et al.
Publicado: (2021)

Drug repurposing: Ibrutinib exhibits immunosuppressive potential in organ transplantation
por: Zhang, Qing, et al.
Publicado: (2018)

Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic
por: Liang, Chengyuan, et al.
Publicado: (2021)

Palliative Medicine in the Era of COVID-19 Pandemic
por: Bhatnagar, Sushma
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3c2g5f9tefnol1lbdct2n8r8qj